References list
- Brunet M, van Gelder T, Asberg A, et al. Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report. Ther Drug Monit. 2019; 41(3):261–307.
- Dasgupta A, Khalil SA, Kl J-D. Analytical performance evaluation of a new Cobas tacrolimus assay on Cobas e411 analyzer: Comparison of values obtained by the CMIA tacrolimus assay and a liquid chromatography combined with tandem mass spectrometric method. Ann Clin Lab Sci. 2016; 46(2):204–208.
- Qin X, Rui J, Xia Y, et al. Multi-center performance evaluations of tacrolimus and cyclosporine electrochemiluminescence immunoassays in the Asia-Pacific region. Ann Lab Med. 2018; 38(2):85–94.
- Fung AWS, Knauer MJ, Blasutig IM, et al. Evaluation of electrochemiluminescence immunoassays for immunosuppressive drugs on the Roche Cobas e411 analyzer. F1000Res. 2017; 6:1832.
- Shipkova M, Vogeser M, Ramos PA, et al. Multi-center analytical evaluation of a novel automated tacrolimus immunoassay. Clin Biochem. 2014; 47(12):1069–1077.
- Guilhaumou R, Lacarelle B, Sampol-Manos E. A rapid, simple and sensitive liquid chromatography-tandem mass spectrometry method for routine clinical monitoring of tacrolimus with the waters masstrak immmunosuppressant kit. Methods Find Exp Clin Pharmacol. 2010; 32(10):737–743.
- Bazin C, Guinedor A, Barau C, et al. Evaluation of the architect tacrolimus assay in kidney, liver, and heart transplant recipients. J Pharm Biomed Anal. 2010; 53(4):997–1002.
- Chen YL, Hirabayashi H, Akhtar S, et al. Simultaneous determination of three isomeric metabolites of tacrolimus (FK506) in human whole blood and plasma using high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2006; 830(2):330–341.
- Levine DM, Maine GT, Armbruster DA, et al. The need for standardization of tacrolimus assays. Clin Chem. 2011; 57(12):1739–1747.
- Annesley TM, McKeown DA, Holt DW, et al. Standardization of LC-MS for therapeutic drug monitoring of tacrolimus. Clin Chem. 2013; 59(11):1630–1637.
- Freeman DJ, Stawecki M, Howson B. Stability of FK 506 in whole blood samples. Ther Drug Monit. 1995; 17(3):266–267.